Libenzapril
Code | Size | Price |
---|
TAR-T27827-1mg | 1mg | £271.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27827-5mg | 5mg | £571.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27827-10mg | 10mg | £783.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27827-25mg | 25mg | £1,139.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27827-50mg | 50mg | £1,500.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T27827-100mg | 100mg | £2,022.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Libenzapril is an inhibitor of angiotensin-converting enzyme.
CAS:
109214-55-3
Formula:
C18H25N3O5
Molecular Weight:
363.414
Pathway:
Metabolism
Purity:
0.98
SMILES:
NCCCC[C@H](N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O)C(O)=O
Target:
Angiotensin-converting Enzyme (ACE)
References
1. Tang JP, Rakhit A, Douglas FL, Melethil S. Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril. Pharm Res. 1992 Feb;9(2):236-43. PubMed PMID: 1553348.
2. Morgan JM, Piraino AJ, Saris SD, Graham CS, Hirschhorn WL, Kochak GM, Choi RL. Inhibition of angiotensin-converting enzyme with libenzapril in normotensive males. J Clin Pharmacol. 1994 Dec;34(12):1177-82. PubMed PMID: 7738213.
3. Kochak GM, Choi RL, deSilva JK, Reydel-Bax P. Pharmacodynamic dependent disposition of the angiotensin converting enzyme inhibitor, libenzapril. J Clin Pharmacol. 1990 Feb;30(2):138-43. PubMed PMID: 2312764.
4. Tang JP, Xu ZQ, Douglas FL, Rakhit A, Melethil S. Increased blood-brain barrier permeability of amino acids in chronic hypertension. Life Sci. 1993;53(25):PL417-20. PubMed PMID: 7902950.